Nvax stock after hours
Jan 24, 2020 · Pursuing vaccines for the virus-of-the-moment has bumped up Novavax's stock on more than one occasion. In the latest move, the company’s share price got a stunning shot in the arm, rising NVAX:NASDAQ GS Stock Quote - Novavax Inc - Bloomberg Markets Stock analysis for Novavax Inc (NVAX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 7 hours ago. Vaccine for COVID-19 Health Novavax Inc (NVAX) Quote | Morningstar Learn about NVAX with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on NVAX.
Oct 25, 2019 · View today's stock price, news and analysis for Novavax Inc. (NVAX). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and …
NVAX : Get live stock charts, earnings, analyst ratings and good investment ideas from independent traders who track NVAX. Follow their trades and see their score card Novavax (NVAX) earnings for the vaccine company's fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday. NVAX interactive stock chart | Novavax, Inc. stock - Yahoo ... At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Novavax (NASDAQ:NVAX) Jim Cramer | Benzinga Jan 01, 2010 · Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
Mar 11, 2020 · Novavax (NASDAQ:NVAX) earnings for fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday. This is despite its diluted losses per share of …
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial. Novavax, Inc. (NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu™, its recombinant quadrivalent seasonal influenza vaccine candidate with its proprietary Matrix-M NVAX - Stocktwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Insider Summary for Novavax Inc. (NVAX) Mar 18, 2020 · Form 3, Form 4, and Form 5 Insider Trades : Last 3 Mo: Last 12 Mo: Number of Insider Trades : 9: 23: Number of Buys: 5: 12: Number of Sells: 4: 11: Net Activity: 6,358 China coronavirus vaccine effort from Novavax is a ...
NVAX | Complete Novavax Inc. stock news by MarketWatch. Open $15.79; Day Range 14.38 - 16.00; 52 Week Range 3.54 - 17.71; Market Cap Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints.
Mar 24, 2020 · Stock Details Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain CHARTS Basic Chart Interactive Chart COMPANY NEWS Company Headlines Press Releases Market Stream STOCK ANALYSIS Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison FUNDAMENTALS
View the real-time NVAX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Novavax against related stocks people have also bought like INO, GERN, ACB, and HEXO. 38,675 people own Novavax on Robinhood on April 3, 2020.
NVAX | Novavax Inc. Stock Price & News - WSJ Novavax Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NVAX stock price. Dow Jones, a News Corp company AFTER HOURS 5:41 PM EDT 03/24/20 $ 12.90
View a financial market summary for NVAX including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NVAX (Novavax Inc.) stock. Stocks Features Premarket Trading After Hours Trading Market Movers 52-Week Highs & Lows Stock Order Imbalance Unusual Stock Volume Morning Novavax, Inc. (NVAX) Stock Price, Quote, History & News ... Novavax (NVAX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. Novavax (NVAX) closed the most recent trading day at $13.86, moving -1.21% from the previous trading session. Emergent BioSolutions Inc. (EBS) today announced an agreement NVAX Stock Quote - Novavax, Inc. Stock Price Today Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology.